Breaking News

I Peace Granted ISO 17025: 2017 Compliant Accreditation

Also accredited for a quantitative real-time PCR method to detect residual Sendai virus vectors in the reprogrammed cells.

I Peace, Inc., a GMP cell contract development and manufacturing organization (CDMO) specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, reported that its Palo Altoquality control testing facility has been accredited as ISO 17025: 2017 compliant. The accreditation was certified by ANSI National Accreditation Board. The tests in the scope of accreditation center on the characterization of iPSCs and include cell count and viability per USP , detection of pluripo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters